Aspira Women's Health Inc. Stock News

Aspira (AWH) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Aspira Women's Health Inc. (NASDAQ:AWH ) Q4 2022 Earnings Conference Call March 22, 2023 4:30 PM ET Company Participants Nicole Sandford - President & Chief Executive Officer Ryan Phan - Chief Scienti

Aspira (AWH) delivered earnings and revenue surprises of 33.33% and 10.29%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

AUSTIN, Texas, March 03, 2023 (GLOBE NEWSWIRE) -- Aspira Women's Health Inc. (Nasdaq: AWH), a bio-analytical based women's health company focused on gynecologic disease, today announced that the compa

Aspira Women's Health Inc. (NASDAQ:AWH ) Q3 2022 Earnings Conference Call November 10, 2022 8:30 AM ET Company Participants Nicole Sandford - President and Chief Executive Officer Ryan Phan - Chief Sc

The heavy selling pressure might have exhausted for Aspira (AWH) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in r

Aspira Women's Health, Inc. (NASDAQ:AWH ) Q2 2022 Earnings Conference Call August 10, 2022 8:30 AM ET Company Participants Nicole Sandford - President and Chief Executive Officer Robert Beechey - Chie

Aspira Women's Health, Inc. (NASDAQ:AWH ) Q1 2022 Earnings Conference Call May 11, 2022 8:30 AM ET Company Participants Nicole Sandford - President, Chief Executive Officer and Director Robert Beechey

Aspira (AWH) delivered earnings and revenue surprises of 0% and 5.35%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

AUSTIN, Texas, April 29, 2022 (GLOBE NEWSWIRE) -- Aspira Women's Health, Inc. (Nasdaq: AWH), a bioanalytical-based women's health company, today announced that the company will report its financial re

Aspira Women's Health Inc. (AWH) CEO Nicole Sanford on Q4 2021 Results - Earnings Call Transcript

Aspira (AWH) delivered earnings and revenue surprises of 11.11% and 2.58%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

AUSTIN, Texas, March 15, 2022 (GLOBE NEWSWIRE) -- Aspira Women's Health, Inc. (Nasdaq: AWH), a bioanalytical-based women's health company, today announced that the company will report its financial re

Aspira Women`s Health Inc (AWH) shares closed today at 0.7% above its 52 week low of $1.45, giving the company a market cap of $163M. The stock is currently down 17.5% year-to-date, down 77.2% over the past 12 months, and up 13.6% over the past five years. This week, the Dow Jones Industrial Average fell 0.3%, and the S&P 500 fell 1.9%. Trading Activity Trading volume this week was 41.1% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.0. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by 2645.0% The company's stock price performance over the past 12 months lags the peer average by -675.3% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.